In a second step, we questioned whether metabolic reprogramming could represent a characteristic of liver MØs since, during the development of MASH, the KC population is replaced by Mo-MØs.26 The gene discussed is CALCA; the disease is metabolic dysfunction-associated steatohepatitis.